Castle Biosciences, Inc. CSTL
33.76 USD +0.38 (+1.14%)
As ofNov 19, 2026, 12:47 PM EST
33.45 Day range 34.75
17.72 52-week range 44.28
- YTD
- -13.21%
- 1 year
- -2.57%
CSTL revenue history
Revenue is income from the company’s ordinary business activities.
344,229,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 344,229,000 | 12,160,000 | 3.66% |
| FY 2024 | 2024-12-31 | 332,069,000 | 112,281,000 | 51.09% |
| FY 2023 | 2023-12-31 | 219,788,000 | 82,749,000 | 60.38% |
| FY 2022 | 2022-12-31 | 137,039,000 | 42,954,000 | 45.65% |
| FY 2021 | 2021-12-31 | 94,085,000 | 31,436,000 | 50.18% |
| FY 2020 | 2020-12-31 | 62,649,000 | 10,784,000 | 20.79% |
| FY 2019 | 2019-12-31 | 51,865,000 | 29,079,000 | 127.62% |
| FY 2018 | 2018-12-31 | 22,786,000 | 9,032,088 | 65.67% |
| FY 2017 | 2017-12-31 | 13,753,912 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-01T06:01:08.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
